Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sutro Biopharma (STRO) Other Gross PP&E Adjustments (2017 - 2025)

Sutro Biopharma's Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$13.3 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 29.88% year-over-year to -$13.3 million; the TTM value through Sep 2025 reached -$13.3 million, up 29.88%, while the annual FY2024 figure was $43.3 million, 21.43% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$13.3 million at Sutro Biopharma, up from -$14.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $43.3 million in Q4 2024 and bottomed at -$30.1 million in Q3 2021.
  • The 5-year median for Other Gross PP&E Adjustments is -$20.3 million (2024), against an average of -$9.4 million.
  • The largest annual shift saw Other Gross PP&E Adjustments crashed 50.23% in 2021 before it surged 36.9% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $23.0 million in 2021, then skyrocketed by 36.9% to $31.5 million in 2022, then grew by 13.18% to $35.7 million in 2023, then increased by 21.43% to $43.3 million in 2024, then crashed by 130.8% to -$13.3 million in 2025.
  • Per Business Quant, the three most recent readings for STRO's Other Gross PP&E Adjustments are -$13.3 million (Q3 2025), -$14.8 million (Q2 2025), and -$16.3 million (Q1 2025).